Reports
Reports
Sale
The global human identification market was valued at USD 2.18 billion in 2023 driven by the advancements in technology and the growth in genetic and paternity testing across the globe. The market is expected to grow at a CAGR of 13.64% during the forecast period 2024-2032 and attain a market value of USD 6.87 billion by 2032.
Human identification is a field that determines an individual’s identity depending on their genetic and biological markers with the help of different techniques. It is related to the biometric detection and managing the data in a way that it can be used for a person’s analysis of an individual. The centre of this field is forensic DNA analysis like mitochondrial DNA sequencing, which is important in crime investigations and victim identification. They match the evidence from the crime scenes with the suspects.
Biometric analysis is the determination of the features of a person based on unique physical and behavioral characteristics. It is used for the analytics of different attributes from human outlook or even inner segments. It includes face recognition, voice identification, DNA sequence matching, iris pattern identification, smile detection, fingerprint matching, and others. Due to technological advancements, the speed and precision of this process has witnessed significant enhancements.
Human identification is used in different fields such as forensic science, legal issues, and surveillance or security systems. It is also used in mobile application development. Technological advancements in genomics, biometrics, and data analytics are continuously improving this field, expanding its applications beyond traditional uses.
Growing Technological Advancements to Boost the Market Value
The market is experiencing significant growth due to technological advancements. Key advancements include next-generation sequencing (NGS), automated DNA extraction and analysis, portable DNA testing devices, AI and machine learning, biometric identification, blockchain for data security, and improved software and data analytics tools.
In September 2023, Promega Corporation launched an 8-Dye STR Multiplex Technology which included new tools like the Spectrum CE system and PowerPlex 35GY system. These systems improved the human identification process by supporting complex forensic analyses and producing more complete information. This signifies that the spectrum CE system and PowerPlex® 35GY System can streamline forensic DNA testing, providing comprehensive, accurate results, and enhancing efficiency and reliability in solving difficult cases.
The market is witnessing several trends and developments to improve the current global scenario. Some of the notable trends are as follows:
Key Trends | Impacts |
Rising Crime Rates and Forensic Applications | The rise in crime rates is one of the key factors leading to an increase in the market demand for advanced forensic applications. It can be used in number of processes such as biometric identification, facial recognition, DNA profiling, fingerprint analysis, and forensics. With the advancement in the technology, the efficiency and accuracy are enhanced. In forensics, these tools help in investigations, identifying suspects and missing people. |
Increasing Demand for Biometric Systems | The market is booming due to biometric systems, such as fingerprint, facial, iris, and voice recognition, which offer security and efficiency in personal identification. These systems are crucial in law enforcement, border control, and healthcare. Due to technological advancements, the speed and the precision are enhanced. |
Legal and Regulatory Requirements | Legal and regulatory requirements, such as GDPR and CCPA, which mandate transparency, consent, and accountability in biometric data handling are shaping the market. This has led to companies investing in secure systems and international standards bodies like ISO developing frameworks to harmonize biometric data handling practices. They not only focus on consumer trust but also help in advanced identification technologies innovation and adoption, resulting in a shift towards more secure, transparent, and privacy-focused solutions. |
Growth in Genetic and Paternity Testing | Genetic and paternity testing is growing globally due to their accuracy and cost-effectiveness. The market is driven by increased awareness and accessibility, particularly in resolving paternity disputes and medical diagnostics. Technological advancements like next-generation sequencing and PCR techniques have made these tests more reliable. They are also being integrated into public health initiatives and personalized medicine, further boosting market expansion. As these tests become more accessible, they are expected to continue driving global human identification growth. |
Market Breakup by Type
Market Breakup by Technology
Market Breakup by Application
Market Breakup by End User
Market Breakup by Region
Market Share Based on Technology to Witness Notable Growth
Based on the technology, the market is segmented into microfluidics, polymerase chain reaction (PCR), nucleic acid purification and extraction, automated liquid handling, microarrays, next-generation sequencing (NGS), rapid DNA analysis, and others.
The global human identification market is diverse and consists of various technologies. Microfluidics involves the manipulation of the small volumes of fluids present in the microchannels, which is used in different applications such as DNA analysis. This segment holds a sizeable share of the market.
PCR is a widely used technique in molecular biology, used to amplify the segments of the DNA. It amplifies and analyzes the genetic material in the samples and helps in the analysis. The nucleic acid purification and extraction technique also holds a significant market share. It is the process of isolation of DNA and RNA from the samples which is a very effective method for the extraction and purification of high-quality genetic materials which can be further used in medical and forensic applications.
Based on region, the market report covers North America, Europe, Asia Pacific, Latin America along with the Middle East and Africa.
North America holds a significant share of the human identification market and is expected to grow during the forecast period due to advanced forensic capabilities and genomic science research. The region benefits from strong government funding and regulatory support for DNA profiling and forensic analysis. The presence of key market players and research institutions in countries like the United States and Canada drives growth. Demand for personalized medicine and ancestry testing also aids market expansion.
Europe is expanding in the human identification market, with strong forensic infrastructure and a focus on genetic research. Countries like the UK, Germany, and France are leading in forensic DNA analysis and genomic technology innovation. Government initiatives and regulatory frameworks drive market growth, ensuring the reliability and accuracy of human identification technologies.
The Asia Pacific region is experiencing rapid growth in the human identification market due to investments in healthcare infrastructure, forensic sciences, and genetic research. Countries like China, Japan, and India are expanding DNA profiling capabilities for forensic investigations and medical diagnostics. Increased awareness about genetic diseases and ancestry testing also boosts market demand.
The key features of the market report include patent analysis as well as strategic initiatives including fundings, investments and recent partnerships by the leading players. The major companies in the market are as follows:
Thermo Fisher Scientific
A life sciences and clinical research company, established in 2006 and headquartered in Massachusetts, USA, it is one of the leading medical devices, reagents, and software providers. It also plays a significant role in human identification through its advanced DNA sequencing technologies and forensic DNA analysis solutions.
QIAGEN NV
It is a German multinational assay-based technologies provider, which is well-known for its molecular diagnostics and applied testing. QIAGEN was established in 1984 and has its headquarters in Venlo, Netherlands. They have a role in the human identification market with their DNA extraction kits and PCR technologies, which are important for forensic analysis and genetic testing.
Illumina, Inc.
It is an American biotechnology company established in 1998, with its headquarters in San Diego, California, USA. They have expertise in genomic sequencing and array-based technologies. The company has high-throughput sequencing platforms which are connected to human identification, allowing rapid and accurate DNA sequencing for forensic and genetic analysis.
GE Healthcare Technologies Inc.
Established in 1994, with its headquarters in Chicago, Illinois, USA, this company specializes in medical imaging and diagnostics. They provide technologies and systems that support medical and forensic DNA analysis, contributing to genetic profiling and identification.
Other players in the market include Agilent Technologies, Bio-Rad Laboratories, Inc., Eurofins Scientific SE, Hamilton Bonaduz AG, IntegenX Inc., LGC Limited, National Medical Services, Inc., and Promega Corporation, among others.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Type |
|
Breakup by Technology |
|
Breakup by Application |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Supplier Landscape |
|
Companies Covered |
|
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Human Identification Market Overview
3.1 Global Human Identification Market Historical Value (2017-2023)
3.2 Global Human Identification Market Forecast Value (2024-2032)
4 Vendor Positioning Analysis
4.1 Key Vendors
4.2 Prospective Leaders
4.3 Niche Leaders
4.4 Disruptors
5 Global Human Identification Market Landscape*
5.1 Global Human Identification: Developers Landscape
5.1.1 Analysis by Year of Establishment
5.1.2 Analysis by Company Size
5.1.3 Analysis by Region
5.2 Global Human Identification: Product Landscape
5.2.1 Analysis by Type
5.2.2 Analysis by Technology
5.2.3 Analysis by Application
6 Global Human Identification Market Dynamics
6.1 Market Drivers and Constraints
6.2 SWOT Analysis
6.2.1 Strengths
6.2.2 Weaknesses
6.2.3 Opportunities
6.2.4 Threats
6.3 PESTEL Analysis
6.3.1 Political
6.3.2 Economic
6.3.3 Social
6.3.4 Technological
6.3.5 Legal
6.3.6 Environment
6.4 Porter’s Five Forces Model
6.4.1 Bargaining Power of Suppliers
6.4.2 Bargaining Power of Buyers
6.4.3 Threat of New Entrants
6.4.4 Threat of Substitutes
6.4.5 Degree of Rivalry
6.5 Key Demand Indicators
6.6 Key Price Indicators
6.7 Industry Events, Initiatives, and Trends
6.8 Value Chain Analysis
7 Global Human Identification Market Segmentation (2017-2032)
7.1 Global Human Identification Market (2017-2032) by Type
7.1.1 Market Overview
7.1.2 Consumables
7.1.3 Services
7.1.4 Instruments
7.1.5 Software
7.2 Global Human Identification Market (2017-2032) by Technology
7.2.1 Market Overview
7.2.2 Microfluidics
7.2.3 Polymerase Chain Reaction (PCR)
7.2.4 Nucleic Acid Purification and Extraction
7.2.5 Microarrays
7.2.6 Next-Generation Sequencing (NGS)
7.2.7 Rapid DNA Analysis
7.2.8 Others
7.3 Global Human Identification Market (2017-2032) by Application
7.3.1 Market Overview
7.3.2 Forensic Applications
7.3.3 Paternity Identification
7.3.4 Others
7.4 Global Human Identification Market (2017-2032) by End User
7.4.1 Market Overview
7.4.2 Forensic Laboratories
7.4.3 Research and Academic Institute
7.4.4 Hospitals
7.4.5 Others
7.5 Global Human Identification Market (2017-2032) by Region
7.5.1 Market Overview
7.5.2 North America
7.5.3 Europe
7.5.4 Asia Pacific
7.5.5 Latin America
7.5.6 Middle East and Africa
8 North America Human Identification Market (2017-2032)
8.1 North America Human Identification Market (2017-2032) by Type
8.1.1 Market Overview
8.1.2 Consumables
8.1.3 Services
8.1.4 Instruments
8.1.5 Software
8.2 North America Human Identification Market (2017-2032) by Technology
8.2.1 Market Overview
8.2.2 Microfluidics
8.2.3 Polymerase Chain Reaction (PCR)
8.2.4 Nucleic Acid Purification and Extraction
8.2.5 Microarrays
8.2.6 Next-Generation Sequencing (NGS)
8.2.7 Rapid DNA Analysis
8.2.8 Others
8.3 North America Human Identification Market (2017-2032) by Application
8.3.1 Market Overview
8.3.2 Forensic Applications
8.3.3 Paternity Identification
8.3.4 Others
8.4 North America Human Identification Market (2017-2032) by End User
8.4.1 Market Overview
8.4.2 Forensic Laboratories
8.4.3 Research and Academic Institute
8.4.4 Hospitals
8.4.5 Others
8.5 North America Human Identification Market (2017-2032) by Country
8.5.1 United States of America
8.5.2 Canada
9 Europe Human Identification Market (2017-2032)
9.1 Europe Human Identification Market (2017-2032) by Type
9.1.1 Market Overview
9.1.2 Consumables
9.1.3 Services
9.1.4 Instruments
9.1.5 Software
9.2 Europe Human Identification Market (2017-2032) by Technology
9.2.1 Market Overview
9.2.2 Microfluidics
9.2.3 Polymerase Chain Reaction (PCR)
9.2.4 Nucleic Acid Purification and Extraction
9.2.5 Microarrays
9.2.6 Next-Generation Sequencing (NGS)
9.2.7 Rapid DNA Analysis
9.2.8 Others
9.3 Europe Human Identification Market (2017-2032) by Application
9.3.1 Market Overview
9.3.2 Forensic Applications
9.3.3 Paternity Identification
9.3.4 Others
9.4 Europe Human Identification Market (2017-2032) by End User
9.4.1 Market Overview
9.4.2 Forensic Laboratories
9.4.3 Research and Academic Institute
9.4.4 Hospitals
9.4.5 Others
9.5 Europe Human Identification Market (2017-2032) by Country
9.5.1 United Kingdom
9.5.2 Germany
9.5.3 France
9.5.4 Italy
9.5.5 Others
10 Asia Pacific Human Identification Market (2017-2032)
10.1 Asia Pacific Human Identification Market (2017-2032) by Type
10.1.1 Market Overview
10.1.2 Consumables
10.1.3 Services
10.1.4 Instruments
10.1.5 Software
10.2 Asia Pacific Human Identification Market (2017-2032) by Technology
10.2.1 Market Overview
10.2.2 Microfluidics
10.2.3 Polymerase Chain Reaction (PCR)
10.2.4 Nucleic Acid Purification and Extraction
10.2.5 Automated Liquid Handling
10.2.6 Microarrays
10.2.7 Next-Generation Sequencing (NGS)
10.2.8 Rapid DNA Analysis
10.2.9 Others
10.3 Asia Pacific Human Identification Market (2017-2032) by Application
10.3.1 Market Overview
10.3.2 Forensic Applications
10.3.3 Paternity Identification
10.3.4 Others
10.4 Asia Pacific Human Identification Market (2017-2032) by End User
10.4.1 Market Overview
10.4.2 Forensic Laboratories
10.4.3 Research and Academic Institute
10.4.4 Hospitas
10.4.5 Others
10.5 Asia Pacific Human Identification Market (2017-2032) by Country
10.5.1 China
10.5.2 Japan
10.5.3 India
10.5.4 ASEAN
10.5.5 Australia
10.5.6 Others
11 Latin America Human Identification Market (2017-2032)
11.1 Latin America Human Identification Market (2017-2032) by Type
11.1.1 Market Overview
11.1.2 Consumables
11.1.3 Services
11.1.4 Instruments
11.1.5 Software
11.2 Latin America Human Identification Market (2017-2032) by Technology
11.2.1 Market Overview
11.2.2 Microfluidics
11.2.3 Polymerase Chain Reaction (PCR)
11.2.4 Nucleic Acid Purification and Extraction
11.2.5 Microarrays
11.2.6 Next-Generation Sequencing (NGS)
11.2.7 Rapid DNA Analysis
11.2.8 Others
11.3 Latin America Human Identification Market (2017-2032) by Application
11.3.1 Market Overview
11.3.2 Forensic Applications
11.3.3 Paternity Identification
11.3.4 Others
11.4 Latin America Human Identification Market (2017-2032) by End User
11.4.1 Market Overview
11.4.2 Forensic Laboratories
11.4.3 Research and Academic Institute
11.4.4 Hospitals
11.4.5 Others
11.5 Latin America Human Identification Market (2017-2032) by Country
11.5.1 Brazil
11.5.2 Argentina
11.5.3 Mexico
11.5.4 Others
12 Middle East and Africa Human Identification Market (2017-2032)
12.1 Middle East and Africa Human Identification Market (2017-2032) by Type
12.1.1 Market Overview
12.1.2 Consumables
12.1.3 Services
12.1.4 Instruments
12.1.5 Software
12.2 Middle East and Africa Human Identification Market (2017-2032) by Technology
12.2.1 Market Overview
12.2.2 Microfluidics
12.2.3 Polymerase Chain Reaction (PCR)
12.2.4 Nucleic Acid Purification and Extraction
12.2.5 Microarrays
12.2.6 Next-Generation Sequencing (NGS)
12.2.7 Rapid DNA Analysis
12.2.8 Others
12.3 Middle East and Africa Human Identification Market (2017-2032) by Application
12.3.1 Market Overview
12.3.2 Forensic Applications
12.3.3 Paternity Identification
12.3.4 Others
12.4 Middle East and Africa Human Identification Market (2017-2032) by End User
12.4.1 Market Overview
12.4.2 Forensic Laboratories
12.4.3 Research and Academic Institute
12.4.4 Hospitals
12.4.5 Others
12.5 Middle East and Africa Human Identification Market (2017-2032) by Country
12.5.1 Saudi Arabia
12.5.2 United Arab Emirates
12.5.3 Nigeria
12.5.4 South Africa
12.5.5 Others
13 Regulatory Framework
13.1 Regulatory Overview
13.2 US FDA
13.3 EU EMA
13.4 INDIA CDSCO
13.5 JAPAN PMDA
13.6 Others
14 Patent Analysis
14.1 Analysis by Type of Patent
14.2 Analysis by Publication Year
14.3 Analysis by Issuing Authority
14.4 Analysis by Patent Age
14.5 Analysis by CPC Analysis
14.6 Analysis by Patent Valuation
14.7 Analysis by Key Players
15 Strategic Initiatives
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Supplier Landscape
16.1 Market Share Analysis, By Region (Top 5 Companies)
16.1.1 Market Share Analysis: Global
16.1.2 Market Share Analysis: North America
16.1.3 Market Share Analysis: Europe
16.1.4 Market Share Analysis: Asia Pacific
16.1.5 Market Share Analysis: Others
16.2 Thermo Fisher Scientific Inc.
16.2.1 Financial Analysis
16.2.2 Product Portfolio
16.2.3 Demographic Reach and Achievements
16.2.4 Mergers and Acquisitions
16.2.5 Certifications
16.3 QIAGEN NV
16.3.1 Financial Analysis
16.3.2 Product Portfolio
16.3.3 Demographic Reach and Achievements
16.3.4 Mergers and Acquisitions
16.3.5 Certifications
16.4 Promega Corporation
16.4.1 Financial Analysis
16.4.2 Product Portfolio
16.4.3 Demographic Reach and Achievements
16.4.4 Mergers and Acquisitions
16.4.5 Certifications
16.5 Illumina, Inc.
16.5.1 Financial Analysis
16.5.2 Product Portfolio
16.5.3 Demographic Reach and Achievements
16.5.4 Mergers and Acquisitions
16.5.5 Certifications
16.6 Agilent Technologies, Inc.
16.6.1 Financial Analysis
16.6.2 Product Portfolio
16.6.3 Demographic Reach and Achievements
16.6.4 Mergers and Acquisitions
16.6.5 Certifications
16.7 Bio-Rad Laboratories, Inc.
16.7.1 Financial Analysis
16.7.2 Product Portfolio
16.7.3 Demographic Reach and Achievements
16.7.4 Mergers and Acquisitions
16.7.5 Certifications
16.8 LGC Limited
16.8.1 Financial Analysis
16.8.2 Product Portfolio
16.8.3 Demographic Reach and Achievements
16.8.4 Mergers and Acquisitions
16.8.5 Certifications
16.9 GE HealthCare Technologies Inc.
16.9.1 Financial Analysis
16.9.2 Product Portfolio
16.9.3 Demographic Reach and Achievements
16.9.4 Mergers and Acquisitionsl
16.9.5 Certifications
16.10 National Medical Services, Inc.
16.10.1 Financial Analysis
16.10.2 Product Portfolio
16.10.3 Demographic Reach and Achievements
16.10.4 Mergers and Acquisitions
16.10.5 Certifications
16.11 Hamilton Bonaduz AG.
16.11.1 Financial Analysis
16.11.2 Product Portfolio
16.11.3 Demographic Reach and Achievements
16.11.4 Mergers and Acquisitions
16.11.5 Certifications
16.12 Eurofins Scientific SE
16.12.1 Financial Analysis
16.12.2 Product Portfolio
16.12.3 Demographic Reach and Achievements
16.12.4 Mergers and Acquisitions
16.12.5 Certifications
16.13 IntegenX Inc.
16.13.1 Financial Analysis
16.13.2 Product Portfolio
16.13.3 Demographic Reach and Achievements
16.13.4 Mergers and Acquisitions
16.13.5 Certifications
17 Human Identification Market – Distribution Model (Additional Insight)
17.1 Overview
17.2 Potential Distributors
17.3 Key Parameters for Distribution Partner Assessment
18 Key Opinion Leaders (KOL) Insights (Additional Insight)
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
**The supplier list is not exhaustive. Moreover, we can provide analysis of companies as per custom requests.
Datasheet
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.